– Een smart-alert-onderzoek om antistollingsbehandeling te begeleiden bij patiënten met atriumfibrilleren
SEONGNAM, Zuid-Korea– (BUSINESS WIRE) – Sky Labs, een start-up in de gezondheidszorg, kondigde aan dat CART-I, het ringvormige hartbewakingsapparaat, was verstrekt aan Timothy Betts, hoogleraar geneeskunde aan de universiteit van Oxford, voor zijn klinisch onderzoek.
Professor Timothy Betts is cardioloog en aritmiespecialist. Hij is een sleutelfiguur voor klinisch onderzoek naar hartritmemanagement en universitair hoofddocent cardiovasculaire geneeskunde aan de Universiteit van Oxford. Hij is ook lid van het Oxford Biomedical Research Centre en de Britse vertegenwoordiger in het EHRA National Cardiac Societies Committee.
Patiënten met boezemfibrilleren worden geadviseerd om anticoagulantia te gebruiken om het risico op een beroerte te voorkomen. Het is echter niet eenvoudig om de symptomen te identificeren. Professor Betts is van plan een klinische studie uit te voeren met Sky Labs CART-I, Medtronic Reveal LINQ II en Apple Watch om atriale fibrillatiesymptomen op te sporen en de patiënten te waarschuwen om anticoagulantia in te nemen wanneer dat nodig is.
Sky Labs CART-I Invited to a Clinical Study of Oxford University Professor Betts
– A smart-alert study to guide anticoagulant treatment for patients with atrial fibrillation
SEONGNAM, South Korea–(BUSINESS WIRE)– Sky Labs, a healthcare start-up, announced that CART-I, its ring-type heart-monitoring device, had been provided for Timothy Betts, professor of medicine at Oxford University, for his clinical research.
The world’s first ring-type heart-monitoring device, CART-I developed by Sky Labs. The CART (Cardio Tracker) – I, a ring-type medical device monitors heart signals and detects diseases by using optical sensors. The photoplethysmography (PPG) sensor in the ring monitors the bloodstream in the finger and continuously measures the irregular pulse waves of atrial fibrillation. Electrocardiogram (ECG) can be also measured by simply placing the fingers on the metal part of the ring. Sky Labs provided its CART-I for clinical research of professor Timothy Betts at Oxford University. Professor Betts plans to conduct a clinical study with Sky Labs CART-I to detect atrial fibrillation symptoms and alert the patients to take anticoagulants when needed. (Photo: Business Wire)
Professor Timothy Betts is a cardiologist and arrhythmia specialist. He is a key figure for clinical research in cardiac rhythm management and associate professor of cardiovascular medicine at Oxford University. He is also a member of the Oxford Biomedical Research Center and the UK representative on the EHRA National Cardiac Societies Committee.
Atrial fibrillation patients are advised to take anticoagulants to prevent the risk of stroke. However, it is not easy to identify the symptoms. Professor Betts plans to conduct a clinical study with Sky Labs CART-I, Medtronic Reveal LINQ II and Apple Watch to detect atrial fibrillation symptoms and alert the patients to take anticoagulants when needed.
Fifty patients recruited for the study will be inserted with a Reveal LINQ II implantable cardiac monitor (ICM). Then they will receive a Sky Labs CART-I ring or an Apple Watch. The ability of the ring and the watch to monitor heart rhythm and alert atrial fibrillation episodes will be analyzed in comparison with the ICM.
CART-I is the world’s first ring-type heart-monitoring device. The photoplethysmography (PPG) sensor in the ring monitors the bloodstream in the finger and continuously measures the irregular pulse waves of atrial fibrillation. Electrocardiogram (ECG) can be also measured by simply placing the fingers on the metal part of the ring.
Professor Timothy Betts said, “I’m pleased to conduct a study to monitor the atrial fibrillation of patients by using CART-I and utilize the data to guide atrial fibrillation treatment. CART-I featuring innovative design and multiple functions will be of great help to patients and medical staffs.”
Jack Lee, CEO of Sky Labs, said, “The study will be an opportunity for us to enter the global healthcare market. CART-I will make a good combination with the ICM in monitoring heart rhythm and providing meaningful data for patients and doctors.”
Sky Labs’ CART-I won the Digital Health & Technology Competition of the European Society of Cardiology for 2 consecutive years from 2018. The company was selected as the ‘technology pioneer’ of the World Economic Forum 2019 and invited to the annual forum.
About Sky Labs
Sky Labs developed CART (Cardio Tracker) – I, a ring-type medical device to monitor heart signals and detect diseases by using optical sensors. It monitors atrial fibrillation, which cannot be detected in advance, 24/7. The results can be checked in real time on the CART-app of your smartphone. Very light and water-resistant, the CART ring is easy to use and causes no inconvenience to your daily life. Winning the final of the Grants4Apps held by Bayer, a German multinational pharmaceutical company, in 2017, Sky Labs attracted investment from Bayer Headquarters. Sky Labs and the Charité in Germany, one of Europe’s largest hospitals, have been considering collaborative clinical research in heart-related diseases since May 2018. It is the only Korean company which won the Digital Health and Technology Competition of the European Society of Cardiology for 2 consecutive years. In addition, the company was invited as a technology pioneer to the World Economic Forum 2019.
For Sky Labs
Meet the sun